Comment on

• Once-weekly dalbavancin versus daily conventional therapy for skin infection.

  Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Boucher HW, et al. N Engl J Med. 2014 Jun 5;370(23):2169-79. doi: 10.1056/NEJMoa1310480. N Engl J Med. 2014. PMID: 24897082 Clinical Trial.
• Single-dose oritavancin in the treatment of acute bacterial skin infections.

  Corey GR, Kabler H, Mehra P, Gupta S, Overcash JS, Porwal A, Giordano P, Lucasti C, Perez A, Good S, Jiang H, Moeck G, O'Riordan W; SOLO I Investigators. Corey GR, et al. N Engl J Med. 2014 Jun 5;370(23):2180-90. doi: 10.1056/NEJMoa1310422. N Engl J Med. 2014. PMID: 24897083 Clinical Trial.